These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7284262)

  • 1. New chemical stabilizers, vehicles and delivery systems to enhance efficacy of low strength anthralin formulations.
    van Scott EJ; Yu RJ
    Br J Dermatol; 1981 Aug; 105 Suppl 20():35-8. PubMed ID: 7284262
    [No Abstract]   [Full Text] [Related]  

  • 2. Short contact anthralin in the treatment of psoriasis: a study of different contact times.
    MacDonald KJ; Marks J
    Br J Dermatol; 1986 Feb; 114(2):235-9. PubMed ID: 3947539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison between Antraderm stick (0.5% and 1%) and dithranol paste (0.125% and 0.25%) in the treatment of psoriasis.
    Agrup G; Agdell J
    Br J Clin Pract; 1985 May; 39(5):185-7. PubMed ID: 3907683
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of psoriasis in general practice with short contact dithranol.
    Blomfield I; Sedcole V; Cunliffe WJ
    Practitioner; 1985 Jul; 229(1405):637-41. PubMed ID: 4034473
    [No Abstract]   [Full Text] [Related]  

  • 5. A topical treatment program for psoriasis with low anthralin concentrations.
    Brody I; Johansson A
    J Cutan Pathol; 1977 Oct; 4(5):233-43. PubMed ID: 342554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical treatment of psoriasis with dithranol.
    Farber EM
    Acta Derm Venereol Suppl (Stockh); 1984; 112():11-6. PubMed ID: 6596820
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with the "minute treatment" of psoriasis vulgaris].
    Marosi I; Balogh G; Cseplák G
    Orv Hetil; 1984 May; 125(22):1323-5. PubMed ID: 6728461
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with 2 short-term anthralin therapy schedules].
    Biella U; Heller G; Barth J
    Dermatol Monatsschr; 1983 Jan; 169(1):42-5. PubMed ID: 6832440
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-contact dithranol therapy--a comparison with the Ingram regime.
    Statham BN; Ryatt KS; Rowell NR
    Br J Dermatol; 1984 Jun; 110(6):703-8. PubMed ID: 6733040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paper-tape occlusion of anthralin paste. A new outpatient therapy for psoriasis.
    Pearlman DL; Burns J; Cannon TC; Engelhard CS
    Arch Dermatol; 1984 May; 120(5):625-30. PubMed ID: 6721524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy.
    Schaefer H; Farber EM; Goldberg L; Schalla W
    Br J Dermatol; 1980 May; 102(5):571-3. PubMed ID: 7387901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the response of psoriasis to short-term application of anthralin.
    Marsden JR; Coburn PR; Marks J; Shuster S
    Br J Dermatol; 1983 Aug; 109(2):209-18. PubMed ID: 6871098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin.
    Lowe NJ; Ashton RE; Koudsi H; Verschoore M; Schaefer H
    J Am Acad Dermatol; 1984 Jan; 10(1):69-72. PubMed ID: 6693604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low strength anthralin in psoriasis.
    Montes LF; Wilborn WH; Brody I
    J Cutan Pathol; 1979 Dec; 6(6):445-56. PubMed ID: 42654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of low-strength anthralin in psoriasis. A paired comparison study.
    Marley WM; Hernandez AD; Josephs JA; Dawkins L
    Arch Dermatol; 1982 Nov; 118(11):906-8. PubMed ID: 7138048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory treatment of psoriasis with dithranol sticks--a novel paraffin formulation.
    Brandt H; Gordin A; Mustakallio KK
    Dermatologica; 1985; 171(6):459-62. PubMed ID: 3912226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of Antraderm stick 1% and 2% with dithranol paste 0.25% and 0.5% respectively in the treatment of psoriasis.
    Eilard U; Edin L
    Br J Clin Pract; 1985 Jun; 39(6):232-4. PubMed ID: 4041349
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind comparison of 0.1% dithranol and 17% urea (Psoradrate cream) and 0.25%-dithranol in vanishing cream (Dithrocream) in the treatment of psoriasis.
    Peachey RD; Burton JL
    Clin Exp Dermatol; 1982 Nov; 7(6):625-8. PubMed ID: 6758994
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicologic study of anthralin in an aqueous cream formulation.
    Neill SM; Bugrein A; Coulson IH; Greaves MW
    Cutis; 1984 Dec; 34(6):563-6. PubMed ID: 6518819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-duration ('minutes') therapy with dithranol for psoriasis: a new out-patient regimen.
    Runne U; Kunze J
    Br J Dermatol; 1982 Feb; 106(2):135-9. PubMed ID: 7059509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.